AldoTIaconoMD

Pulmonology • New Hyde Park, NY

Critical Care Medicine, Interventional Pulmonology, Pleural Disease

University of Maryland

Join to view full profile

Dr. Iacono is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Iacono's full profile

Already have an account?

Office
410 Lakeville Rd
Ste 105
New Hyde Park, NY 11042
Phone+1 516-465-5417

Fax+1 516-465-5392

Education & Training

Stony Brook Medicine/University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Brooklyn Hospital CenterResidency, Internal Medicine, 1986 - 1989
University of BolognaClass of 1985

Certifications & Licensure

NY State Medical License 1989 - 2025
MD State Medical License 2005 - 2022
PA State Medical License 1992 - 2006
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Aerosol Cyclosporine for Prevention of Lung Rejection Start of enrollment: 1998 Apr 01
Completed
Phase 2
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients Start of enrollment: 2012 Jul 01
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

1 citations
Prophylactic epinephrine attenuates severe bleeding in lung transplantation patients undergoing transbronchial lung biopsy: Results of the PROPHET randomized trial.
Or Kalchiem-Dekel, Bich-Chieu Tran, Danielle R Glick, Ngoc-Tram Ha, Aldo Iacono
The Journal of Heart and Lung Transplantation. 2023-09-01
4 citations
Lung Transplantation in a New Era in the Field of Cystic Fibrosis.
Wei Huang, Alexander T Smith, Maksim Korotun, Aldo Iacono, Janice Wang
Life. 2023-07-21
6 citations
Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories.
Ananth V Charya, Ileana L Ponor, Adam Cochrane, Deborah Levine, Mary Philogene
The Journal of Heart and Lung Transplantation. 2023-02-01

Journal Articles

The Use of Extended Criteria Donors Decreases One-Year Survival in High-Risk Lung Recipients: A Review of the United Network of Organ Sharing Database
Charles F Evans, James S Gammie, Pablo G Sanchez, Keshava Rajagopal, Aldo T Iacono, Si M Pham, Matthew J Mulligan, Bartley P Griffith, Journal of Thoracic and Cardiovascular Surgery

Press Mentions

Inhaled Immunosuppressant May Increase Survival, Pulmonary Function After Lung TransplantNovember 14th, 2019
Little-Used Drug Combination May Extend the Lives of Lung Transplant PatientsAugust 28th, 2019

Grant Support

Aerosol Cyclosporine For Prevention Of Lung RejectionNational Heart, Lung, And Blood Institute2001

Other Languages

Italian